Regeneron Pharmaceuticals, Inc. Price Today
Regeneron Pharmaceuticals, Inc.
REGN
Healthcare
$84.09B
💰
Market Cap
20.8
💸
Price to Earnings
$36.8
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
14 |
Strong Buy |
8 |
Hold |
9 |
Sell |
1 |
Strong Sell |
0 |
REGN Price Forecast Target
766.4 👉 1045.0 +36%
REGN EPS Forecast
36.8 👉 42.4 +15%
Financials
Profit Margin
34 %
Revenue Growth
10.5 %
Dividend
$ 0
Held Percent
2.5% - Insiders
89.4% - Institutions
8.1% - Public
Major Fund Holders
-
💰 FMR, LLC $7.8B
-
💰 Blackrock Inc. $7.7B
-
💰 Vanguard Group Inc $7.3B
-
💰 JP Morgan Chase & Company $5.2B
-
💰 Capital World Investors $4.8B
Stock Ideas
Nancy Pelosi Portfolio
Nancy Pelosi is the Speaker of the United States House of Representatives and a savvy investor. Her personal portfolio is heavily weighted towards large-cap tech stocks, such as Apple and Microsoft. She also owns shares in several consumer staples a…
Warren Buffet Portfolio
Invest like the oracle himself! View the stocks that Warren Buffett holds in the Berkshire Hathaway portfolio.
Ken Fisher Portfolio
Ken Fisher is a prominent American investment analyst, author, and the founder of Fisher Investments, a global investment firm managing billions of dollars in assets for individual and institutional clients. As a highly successful investor and fina…
Israel Englander Portfolio
Israel Englander, a notable figure in the finance industry, began his journey by obtaining his undergraduate degree from NYU before venturing into trading on the American Stock Exchange (AMEX), where he found early success. In 1989, he went on to es…📮FAQ
Some Frequently Asked Questions.
The Regeneron Pharmaceuticals, Inc. industry is Biotechnology
The Regeneron Pharmaceuticals, Inc. sector is Healthcare
The Regeneron Pharmaceuticals, Inc. forecasted predicted Price to Earnings PE ratio is 18.1
The Regeneron Pharmaceuticals, Inc. Price to Earnings PE ratio is 20.8
The Market Capitalization of Regeneron Pharmaceuticals, Inc. is $84.09B
There are total of 101370706 float shares with 89.4% held by Institutions and 2.5% held by insiders
The MRegeneron Pharmaceuticals, Inc. forecasted Earnings per Share EPS is $42.4
The Regeneron Pharmaceuticals, Inc. Earnings per Share EPS is 36.8
The Regeneron Pharmaceuticals, Inc. company has $7020000000 gross profits with 34 profit margins
The Regeneron Pharmaceuticals, Inc. Earnings Growth is 0.138% with 0.136% quarterly earnings growth
The Regeneron Pharmaceuticals, Inc. Revenue is $12670799872 with 0.105 revenue growth
The price target for Regeneron Pharmaceuticals, Inc. stock is $1045.0 for the high target and $650.0 for the low target
The consensus analyst recommendations for Regeneron Pharmaceuticals, Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Regeneron Pharmaceuticals, Inc. is Buy, with the following breakdown:
- Buy: 14
- Strong Buy: 8
- Hold: 9
- Sell: 1
- Strong Sell: 0
The Beta of Regeneron Pharmaceuticals, Inc. is 0.2
The dividend of Regeneron Pharmaceuticals, Inc. is $0
The dividend yield of Regeneron Pharmaceuticals, Inc. is 0%
The biggest institutional and mutual fund holders of Regeneron Pharmaceuticals, Inc. stock are
- FMR, LLC
- Blackrock Inc.
- Vanguard Group Inc
- JP Morgan Chase & Company
The Regeneron Pharmaceuticals, Inc. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0